MAST Trial: Multi-modal Analgesic Strategies in Trauma

• Status: Completed
• Trial end date: 2019-07-03
• Target enrollment: 0
• Participant gender: All

Summary

This is a comparative effectiveness study of current pain management strategies in acutely injured trauma patients. Two different multi-modal, opioid minimizing analgesic strategies will be compared [original multimodal pain regimen (MMPR) compared to multi-modal analgesic strategies for trauma (MAST) MMPR].

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Collaborator: National Center for Advancing Translational Science (NCATS)
• Treatments: Acetaminophen; Analgesics; Analgesics, Opioid; Anesthetics; Celecoxib; Gabapentin; gamma-Aminobutyric Acid; Ketorolac; Ketorolac Tromethamine; Lidocaine; Naproxen; Pregabalin; Tramadol

Criteria

Inclusion Criteria:

• All patients admitted to the trauma service who are 16 years and older.

Exclusion Criteria:

• pregnant

• prisoner

• patients placed in observation (i.e. not admitted to the hospital)